Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels

Psychoneuroendocrinology

Volumn 29, Issue 2, 2004, Pages 201-214

  T'Sjoen, G ^a   Goemaere, S ^a   De Meyere, M ^a   Kaufman, J M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Aging male; Aging males' symptoms; Male climacteric; Questionnaire; Symptoms; Testosterone

Indexed keywords

ANDROGEN; GONADOTROPIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; AGING; ANDROGEN BLOOD LEVEL; ANDROPAUSE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; CLIMACTERIUM; CORRELATION ANALYSIS; GONADOTROPIN BLOOD LEVEL; HEALTH; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; STEROID BLOOD LEVEL; SYMPTOMATOLOGY; SYNDROME; TESTOSTERONE BLOOD LEVEL; WELLBEING;

EID: 0242352515     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00023-4     Document Type: Article

References (30)

1. Barrett-Connor E., Von Mühlen D.G., Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J. Clin. Endocrinol. Metab. 84:1999;573-577.
2. Deslypere J.P., Kaufman J.M., Vermeulen T., Vogelaers D., Vandalen J.L., Vermeulen A. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J. Clin. Endocrinol. Metab. 64:1987;68-73.
3. Dunbar N., Gruman C., Reisine S., Kenny A. Comparison of two health status measures and their associations with testosterone levels in older men. Aging Male. 4:2001;1-7.
4. Ferrini R., Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am. J. Epidemiol. 147:1998;750-754.
5. Goemaere S., Van Pottelbergh I., Zmierczak H., Toye K., Daems M., Demuynck R., et al. Inverse association between bone turnover rate and bone mineral density in community-dwelling men >70 years of age: no major role of sex steroid status. Bone. 29:2001;286-291.
6. Gray A., Berlin J., McKinlay J., Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J. Clin. Epidemiol. 44:1991;671-684.
7. Heinemann L., Zimmermann T., Vermeulen A., Thiel C., Hummel W. A new "aging males" symptoms' rating scale. Aging Male. 2:1999;105-114.
8. Hobson P., Bhowmick B., Meara J. Use of the SF-36 questionnaire in cerebrovascular disease. Stroke. 28:1997;464-465.
9. Kaufman J.M., Vermeulen A. Declining gonadal function in elderly men. Baillieres Clin. Endocrinol. Metab. 11:1997;289-309.
10. Linn M.W., Linn B.S. The rapid disability rating scale-2. J. Am. Geriatr. Soc. 30:1982;378-382.
11. Mak R., De Backer G., Kornitzer M., De Meyer J.M. Prevalence and correlates of erectile dysfunction in a population based study in Belgium. Eur. Urol. 27:2002;1-7.
12. Martin F., Yeo A., Sonksen P. Growth hormone secretion in elderly men: aging and the somatopause. Ballièrre's Clin. Endocrinol. Metab. 11:1997;223-250.
13. McHorney C.A., Ware J.E. Jr., Rogers W., Raczek A.E., Lu J.F. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 30:1992;253-265.
14. Morley J.E., Perry H.M. Androgen deficiency in aging men. Med. Clin. North Am. 83:1999;1279-1289.
15. Morley J.E., Perry H.M. III, Kaiser F.E., Kraenzle D., Jensen J., Houston K., et al. Effect of testosterone replacement therapy in old hypogonadal males: a preliminary study. J. Am. Geriatr. Soc. 41:1993;149-152.
16. Morley J.E., Charlton E., Patrick P., Kaiser F.E., Cadeau P., McCready D., et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 49:2000;1239-1242.
17. Perry P.J., Lund B.C., Arndt S., Holman T., Bever-Stille K.A., Paulsen J., et al. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann. Clin. Psychiatry. 13:2001;75-80.
18. Rudman D., Drinka P.J., Wilson C.R., Mattson D.E., Scherman F., Cuisinier M.C., et al. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin. Endocrinol. 40:1994;653-661.
19. Smith K.W., Feldman H.A., McKinlay J.B. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in aging men. Clin. Endocrinol. 53:2000;703-711.
20. Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am. J. Psychiatry. 155:1998;1310-1318.
21. Swerdloff R.S., Wang C. Androgen deficiency and aging in men. West. J. Med. 159:1993;579-585.
22. Tenover J.L. Androgen administration to aging men. Endocrinol. Metab. Clin. North Am. 23:1994;877-892.
23. Tenover J.L. Male hormone replacement therapy including "andropause" Endocrinol. Metab. Clin. North Am. 27:1998;969-987.
24. Van Den Saffele J.K., Goemaere S., De Bacquer D., Kaufman J.M. Serum leptin levels in healthy aging men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? Clin. Endocrinol. (Oxf.). 51:1999;81-88.
25. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84:1999;3666-3672.
26. Vermeulen A. Androgen replacement therapy in the aging male. a critical evaluation. J. Clin. Endocrinol. Metab. 86:2001;2380-2390.
27. Vermeulen A., Kaufman J.M., Giagulli V.A. Influence of some biological indices on sex hormone binding globulin an androgen levels in aging and obese males. J. Clin. Endocrinol. Metab. 81:1996;1821-1827.
28. Wang C., Alexander G., Berman N., Salehian B., Davidson T., McDonald V., Steiner B., Hull L., Callegari C., Swerdloff R.S. Testosterone replacement therapy improves mood in hypogonadal men, a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;3578-3583.
29. Wang C., Swerdloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., et al. Transdermal testosterone gel improves sexual function, mood, muscle strength and body composition parameters in hypogonadal men, Testosterone Gel Study Group. J. Clin. Endocrinol. Metab. 85:2000;2839-2853.
30. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med. Care. 30:1992;473-483.